粒子-药厂前接收器 //www.novoestroim.com 01J2021123908+00 en-US 时钟 一号 https://wordpress.org/?v=5.7.2 TPLS预测双螺旋湿过程和配方开发//www.novoestroim.com/news/tpls-twin-screw-wet-granulation/ 汤姆 弗里2021年6月25日2.30:50+00 连续制造 缩放式 新闻发布 启动程序 配方 //www.novoestroim.com/?p=230960
TPLS as predictive platform for twin-screw wet granulation process and formulation development

In recent years, the interest in continuous manufacturing techniques, such as twin-screw wet granulation, has increased.然而,对原材料属性和流程设置组合对粒子质量属性影响的理解仍然有限。研究开发T形偏最小方块模型 [.]

Der Beitrag TPLS预测平台双片微粒过程和配方开发 erschienzu

TPLS as predictive platform for twin-screw wet granulation process and formulation development

In recent years, the interest in continuous manufacturing techniques, such as twin-screw wet granulation, has increased.对原材料属性和流程设置组合对粒子质量属性的影响的理解仍然有限 。

TPLS模型预测能力还用于寻找配方组成和双片粒子进程设置的适当组合,以产生期望粒子质量属性。

Der Beitrag TPLS as predictive platform for twin-screw wet granulation process and formulation development erschien zuerst auf Pharma Excipients.

开发并评价混合用量表,内含排气处理//www.novoestroim.com/news/dosage-form-desmopressin-acetate/ 汤姆 wed2021年6月16日2.30:04+00 宾德 千岛市 电影前 缩放式 HPPC-Hypraymetellose 晶体 磁子Stearate Megle游戏 新闻发布 启动程序 配方 //www.novoestroim.com/?p=228880
graphical abstract of Development and evaluation of a composite dosage form containing desmopressin acetate for buccal administration

Desmopressin acetate (DDAVP) is an oligopeptide indicated for the treatment of primary nocturnal enuresis, for example.DDAVP口服可用性差加速转向替代管理路线,如鼻和Oomucosal, 鼻管理导致高度波动增加不良副作用风险研究的目的是使用ss/www.pharmaexccepties.com/news/dosage-form-dempressin-a

graphical abstract of Development and evaluation of a composite dosage form containing desmopressin acetate for buccal administration

Desmopressin acetate (DDAVP) is an oligopeptide indicated for the treatment of primary nocturnal enuresis, for example.DDVP口服可用性差加速转向替代管理路径,如鼻线和Oomucosal, 鼻管结果高波动增加不良副作用风险。

ap>Aim研究使用新的复合用量表(双层双片粘模表)通过Oomucosal路提供DDAVP,通过精确下药减少不良副作用风险DDAVP以微粒形式嵌入固态矩阵中,并对比直接分片(AV > 30)和粒子后加分片(AV=17.86)。单以粒状和损耗补法(AV=11.27)制成并立即释放毒品(7-8分钟后大于80%)和快速分解(<49s)制片Permation研究与临床相关剂量(200微g)相隔最长1小时,结果可见渗透系数4.90x10sup##6 cmsThus, a step towards controlled and dose-accurate transmucosal delivery of systemically active DDAVP could be achieved.

Download the full article as a PDF here or read it here

Materials: In this study, desmopressin acetate (PolyPeptide laboratories, Limhamn, Sweden) was used as the active pharmaceutical ingredient.

For the preparation of the MTs, α-lactose monohydrate (Flowlac 100, Meggle, Wasserburg, Germany), magnesium stearate (Parteck LUB MST, Merck, Frankfurt a.M., Germany) and fumed silicon dioxide (Aerosil 200, Evonik, Darmstadt, Germany) were used.Povidone30s.com/product/kollidon-30/Glycerol85%(Caelo,Hilden,德国)和Triecycortate(Caelo,Hilden,德国)被选为增塑剂Carmellose-nitrium (CMC na),水解法中20%(WalocelC30PA09,DowwwwfCellulosics,Bomlitztectirele(HPLC等级)、orth-phosricare(85%,p.a.)和formicare(98%,p.a.)从AppliChem(Darmstadt,德国)购买乙醇(99%)、盐酸(0.1N)和二联氢磷酸由VWR化学公司提供(Langenfeld,德国)。缓冲成分包含蒸馏水中的10mm二叉磷酸,pH值(pH6.8或7.4)用正对二叉酸调整。

生物膜系统由 PermeaPadBurchardt,TanjaCKnaab、Jrg Breitkreutz和Bjern Fischer开发并评价复合用量表,内含排气管学词表,
国际药理学杂志:X2021org/10.1016/j.jpx.2021100082.

Der Betrag
药态不定固态分布:对制造策略审查//www.novoestroim.com/news/amorphous-solid-dispersion-manufacturing-strategies/ Philippe语言 Sun,06Jun202112:27+00 巴斯夫 生物可用性增强 缩放式 热熔溢出 HPPC-Hypraymetellose 新闻发布 溶性增强 溶剂 启动程序 配方 //www.novoestroim.com/?p=226885

Amorphous solid dispersions (ASDs) are popular for enhancing the solubility and bioavailability of poorly water-soluble drugs.使用各种方法制作asds并出现新手法本审查更新概述制作asds技术物理稳定性是ASD关键质量属性,配方效果 [.]

DerBeitrag

Amorphous solid dispersions (ASDs) are popular for enhancing the solubility and bioavailability of poorly water-soluble drugs.使用各种方法制作asds并出现新手法本审查更新概述制作asds技术物理稳定性是ASD关键质量属性,已讨论了配方、设备及流程变量的影响,并讨论了下游处理对ASD物理稳定性的影响。选择策略建议确定合适的制造方法,这些方法可能有助于开发满足物理稳定性a/p/struct/dowload全文本 :Bhujbal, Biplob Mitra, Uday Jain, Yuchuan Gong, Anjali Agrawal, Shyam Karki, Lynne Taylor, Sumit Kumar, Qi Zhou, Pharmaceutical amorphous solid dispersion: A review of manufacturing strategies, Acta Pharmaceutica Sinica B, 2021, ISSN 2211-3835, https://doi.org/10.1016/j.apsb.2021.05.014 (https://www.sciencedirect.com/science/article/pii/S2211383521001805)

Commonly used polymers for ASD preparation

PolymerTg(°C)Solubility in solvents
Hydroxypropyl methylcellulose175‒185Water, ethanol:dichloromethane (1:1, 2:1), methyl acetate:methanol (1:1)
Hydroxypropyl methylcellulose acetate succinate100‒110Caustic water, acetone, methanol, dichloromethane, chloroform
Hydroxypropyl methylcellulose phthalate133‒137Water, acetone, ethyl acetate, methyl ethyl ketone, ethanol:dichloromethane (1:1) methanol, dichloromethane, tetrahydrofuran
Polyvinylpyrrolidone175‒180Water, acetone, ethanol, methanol, ethyl acetate, methyl ethyl ketone, dichloromethane, tetrahydrofuran
Polyvinylpyrrolidone/vinyl acetate70‒110Water, acetone, ethanol, methanol, ethyl acetate, methyl ethyl ketone, dichloromethane, tetrahydrofuran
Polymethacrylates derivatives (Eudragit®-L100, S100)>150Water (only L100), acetone, ethanol, methanol, ethanol:dichloromethane (1:1)
Cellulose acetate phthalate160‒170Acetone, ethyl acetate, methyl ethyl ketone
Soluplus®72water, acetone, ethanol, methanol, dichloromethane

Source: Pharmaceutical amorphous solid dispersion: A review of manufacturing strategies

Conclusions
A successful development of amorphous solid dispersion formulations depends on three primary factors: active pharmaceutical ingredient properties, stabilizing polymer, and processing technology.聚合物为稳定药态化提供基础和基本基础,过程提供将系统变换成非态式所需的能量进程有效性对生成、捕捉和保存无变形式至关紧要成功这些过程取决于处理时间和超饱和条件形成固化散射时产生。

尽管在1960年代初发现固化散射,但用固化散射概念解决溶解挑战数十年来一直有限,部分原因是缺乏商业上可行的处理技术。然而,过去20年在开发药用ASD产品方面取得了显著进展,因为我们对ASD系统及其制造技术的理解有了相当大的发展,除开发数项产品外,还产生数项商业产品。喷雾干燥和HME成为制药行业ASD准备的主体,而更新方法则不断添加到工具箱中,保证提高产品质量、生产率和/或提高性能。

DerBeitrag
热熔溢出:高亮制药应用最近的进展//www.novoestroim.com/news/hme-recent-pharmaceutical-advances/ 汤姆 卫星2021年5月22日12:30:53+00 3D打印 受控发布前接收器 缩放式 热熔溢出 新闻发布 溶性增强 启动程序 配方 //www.novoestroim.com/?p=223444
graphical abstract of Hot-melt extrusion: Highlighting recent advances in pharmaceutical applications

Hot-melt extrusion (HME) has emerged as a pioneering manufacturing technology for pharmaceutical industries, and the utilization is overgrowing due to its unit operation, cost-effectiveness, solvent-free nature, and continuous manufacturing as compared to conventional techniques.首要重心应放在研究配方和过程参数上,以满足需求。修改设备 [.]

Der Beitrag Hot-melt扩展语

graphical abstract of Hot-melt extrusion: Highlighting recent advances in pharmaceutical applications

Hot-melt extrusion (HME) has emerged as a pioneering manufacturing technology for pharmaceutical industries, and the utilization is overgrowing due to its unit operation, cost-effectiveness, solvent-free nature, and continuous manufacturing as compared to conventional techniques.首要重心应放在研究配方和过程参数上,以满足需求。By modifying the equipment design and varying a few processing conditions, a myriad of different dosage forms for various applications can be developed.

Highlights

This paper describes the Hot-melt extrusion (HME) equipment, process and materials.

Recent advancements in the applications of HME are reviewed.

Opportunities for HME technology in the veterinary field are discussed.

Recent patents of last five years in field of HME are presented.

An insight on pharmaceutical HME market globally is elucidated.

In-depth pre-formulation research is required for the rational selection of an active pharmaceutical ingredient, carrier, and additives for the smooth and continuous functioning of the HME process to achieve the desired product.近些年来,审查渠道从全局角度分析几种设备组件、处理需求、HME使用的材料和各种药送系统使用HME综合论文介绍数大新契机和创新方法,如三维打印剂量表、滥用确定式配方、共发药、时代药交付、联播器、纳米技术、半固片、双片粒子和多项应用。

文章还简要洞察2016至2024年间HME制药市场的全球状况Latterst,本审查汇总了最近四年HME数项应用,用表格方式提供药物,方便阅读文章试图为在这一领域工作的公式论者打下书目基础并推广这一领域的深入调查。

s/www.sciencedent.com/science/article/abs/pii/S1773224721001325热熔溢出:强调药方应用的最新进展,《药品科技杂志》,第63卷,2021年https://doi.org/10.1016/j.jddst.2021.102452.

Der Beitrag Hot-melt extrusion: Highlighting recent advances in pharmaceutical applications erschien zuerst auf Pharma Excipients.

改善一维人口平衡模型双片网格使用识别性分析//www.novoestroim.com/news/model-twin-screw-wet-granulation/ Philippe语言 2021年5月18日12:30:28+00 宾德 DFE药店 杜邦Pharma 缩放式 HPC-液片纤维素 晶体 微晶体细胞 新闻发布 启动程序 配方 //www.novoestroim.com/?p=222659
graphical abstract of Twin-Screw Wet Granulation by Using Identifiability Analysis

Recently, the pharmaceutical industry has undergone changes in the production of solid oral dosages from traditional inefficient and expensive batch production to continuous manufacturing.最新进步包括更多使用连续双螺旋湿粒子并应用高级建模工具,如人口平衡模型scre-wet-granations/

graphical abstract of Twin-Screw Wet Granulation by Using Identifiability Analysis

Recently, the pharmaceutical industry has undergone changes in the production of solid oral dosages from traditional inefficient and expensive batch production to continuous manufacturing.最新进步包括更多使用连续双螺旋湿粒子并应用高级建模工具,如人口平衡模型然而,加深对粒子内物理过程的了解并改进当前人口平衡模型是连续生产过程在实践中取得成功所必不可缺的。在这次研究中,通过识别性分析修改湿带原聚合内核,改进了双层粒子粒子进程的现有单维PBM此外,成功应用策略减少模型参数数,以在湿带和kneading区校准发现湿带新聚合内核可复制粒子大小分布法,该分布法在不同过程条件和不同类型的配方中实验观察到,这些配方在水益性和API富集度方面各异。最后,据观察模型参数不仅可与物性连通,还可与液化对固化比连通,为创建通用PBM预测新配方粒度分布铺路.

/squarte/dowloadVan Hawermeren D.皮特斯M德比尔TNewns,I.a href='s/www.mdpi.com/1999-4923/13/5692'目标s='blank'rehttps://doi.org/10.3390/pharmatutics13050692

/granti三种低高富集性活性药素研究因此,每种配方基于水益性使用2或3因子,详见表1中的细节过程条件选择稳定操作设备并视每种配方的可处理性获取相似粒子[21,22]低浓度配方含5%(w/w)API、5%(w/w)hyproprocellose(dow化学公司Midland,MIUSA)、15%(w/w)、微晶体素Crystaleulose高富集度配方含50%API、5%(w/w)hyproprocellose(Dow化学公司,Midland,MI,USA)、15%(w/w)mcrystlineeulose(AvivellPH101FMC费城PAPA,USA)和30%(w/w)lce单水合物(Lactochem样本采集地点为桶内四处,图1显示红色标签通过使用第二个液添加端口,这些测量是可能的:这使我们能够模拟桶尾这些不同带的粒子行为,这样粒子可以连续收集而无需螺旋拉出This method is described in full detail in the work of Verstraeten et al.


Newsletter Registration

All Excipient Production Sites With GMP Certification

Der Beitrag Improvement of a 1D Population Balance Model for Twin-Screw Wet Granulation by Using Identifiability Analysis erschien zuerst auf Pharma Excipients.

始发者及其属性//www.novoestroim.com/news/excipients-attributes-granulation/ 汤姆 2021年5月18日05:30:02+00 缩放式 新闻发布 启动程序 配方 //www.novoestroim.com/?p=222529
Handbook of Pharmaceutical Granulation Technology

This chapter discusses different excipients traditionally used in granulation applications and the emerging high-functionality co-processed excipients that can improve granulation processing.成功制造片片或胶囊需要公式师考虑数项因素这些决定因素包括剂量水平药本身的物理化学特征,如稳定性、可溶性、可流性 和 [.]

DerBeitrag

Handbook of Pharmaceutical Granulation Technology

This chapter discusses different excipients traditionally used in granulation applications and the emerging high-functionality co-processed excipients that can improve granulation processing.成功制造片片或胶囊需要公式师考虑数项因素 。

药本身物理化学特征,如稳定性、可溶性、可流性及紧凑性归根结底设备组成最终用量单元,即胶囊填充机或平板机各种粒子处理过程可选择数个前接收者应对不良药物特性构成的挑战,并传递预想性能到工序材料和成品中。

与粒子处理相关的复杂性、变异源和成本已导致需要高性前接收者更好地应对这些挑战并可能完全避免粒子化本章讨论前接收者制作各种固态剂量表的重要性和特征对最终剂量表质量属性的影响问题 。


Newsletter Registration

All Excipient Production Sites With GMP Certification

Der Beitrag Excipients and Their Attributes in Granulation erschien zuerst auf Pharma Excipients.

连续双螺旋缩图:概述设计设备设计方面最近的进展和机会//www.novoestroim.com/news/continuous-twin-screw-granulation-review/ 汤姆 Frii,2021年5月14日12:30:29+00 宾德 缩放式 晶体 曼尼妥 新闻发布 冲动剂 启动程序 配方 //www.novoestroim.com/?p=221551
Continuous Twin Screw Granulation: A Review of Recent Progress and Opportunities in Formulation and Equipment Design

Continuous twin screw wet granulation is one of the key continuous manufacturing technologies that have gained significant interest in the pharmaceutical industry as well as in academia over the last ten years.与批量操作的湿粒子技术相比有相当大的优势,例如高剪粒子和流水床粒子,数个 [.]

Beitrag

Continuous Twin Screw Granulation: A Review of Recent Progress and Opportunities in Formulation and Equipment Design

Continuous twin screw wet granulation is one of the key continuous manufacturing technologies that have gained significant interest in the pharmaceutical industry as well as in academia over the last ten years.与批量操作的湿粒子技术相比,如高剪片粒子和流体粒子处理法有相当大的优势,多家设备制造商设计了自己的制造搭建程序。

然而,大多数研究仍然侧重于单片(常有安慰剂)配方,因此难以评估所得结果的一般有效性因此,当前审查概述连续双螺旋湿粒子领域最近的进展,特别注重配方方面和原材料特性的重要性。service-Screw-Servation-Service-Recent-Servation-Equipment-Defer.pdf目标ss//blankss/nopleer维瓦特市Vanhoorne连续双螺旋粒子:《设计设备设计最新进度和机会回顾》, 药理 2021 , 13 ,668https://doi.org/10.3390/pharmatutic 药厂放大器//www.novoestroim.com/news/binders-pharmaceutical-granulation/ 汤姆 太阳2021年5月9日07:30:38+00 宾德 缩放式 新闻发布 启动程序 配方 //www.novoestroim.com/?p=220402

Handbook of Pharmaceutical Granulation Technology

Binders or "granulating agents" are a critical formulation component in tablets made by direct compression, as well as dry, wet, and melt granulation, ensuring appropriate plasticity, compactibility, and binding ability.湿粒化中,表湿能力允许潮湿状态中分片面相接和凝聚对质量属性至关重要Traditionally, binder […]

Der Beitrag Binders in Pharmaceutical Granulation erschien zuerst auf Pharma Excipients.

Handbook of Pharmaceutical Granulation Technology

Binders or "granulating agents" are a critical formulation component in tablets made by direct compression, as well as dry, wet, and melt granulation, ensuring appropriate plasticity, compactibility, and binding ability.湿粒化中,表湿能力允许潮湿状态中分层面相接和凝聚对质量属性至关重要。

传统式绑定选择一直是公司和个人的经验体验和偏好然而,理解机械化和量化粒子工程和材料科学方面粒子绑定和片片集的进展现在允许更合理和以科学为基础的绑定过程In this chapter, we review the physical-chemical properties of the major classes of binders in current pharmaceutical and commercial use, and provide a practical, rational guide to binder selection and use in the context of the physical-chemical properties of the substrate and the binder, including incompatibilities caused by impurities.

Recent advances in mechanistic understanding of particle engineering and granulation technology will be discussed in detail, specifically the importance of selecting binders with a focus on appropriate thermo-plastic and deformation characteristics, surface energetics, wetting, spreadability, and mechanical properties of the system.

Read the article here

Article information: Parind M.德赛 赖华昌 保尔万夏兴Handbook of Pharmaceutical Granulation Technology, 2021.

Der Beitrag Binders in Pharmaceutical Granulation erschien zuerst auf Pharma Excipients.

药材和前接收特征//www.novoestroim.com/news/drug-substance-excipient-characterization/ 汤姆 弗里2021年5月7日14:34:47+00 缩放式 新闻发布 启动程序 配方 //www.novoestroim.com/?p=220391
Handbook of Pharmaceutical Granulation Technology

Characterization of drug substances and excipients is a very important step at the preformulation phase of product development.虽然测试需要更多时间和费用,但如果成品不符合规格,不进行适当的定性测试对制造商甚至可能更高代价原材料特性创建 uns/www.pharmaexccidents.com/news/drug-substance-exccident-descript/

Handbook of Pharmaceutical Granulation Technology

Characterization of drug substances and excipients is a very important step at the preformulation phase of product development.测试将增加时间和成本,但如果成品不符合规格,不进行适当的定性测试对制造商甚至会更高代价。

药前粒子大小变化、晶体形式变化和溶性变化可能进一步影响药产品生物药理质量缺少这类信息使公式设计师没有什么回旋余地当编程开发或进程升级时出现问题时采取补救行动从原材料特征学中获取的知识也可以帮助改进材料采购规范 。

本书章批判性评价从常用到最新技术等技术,使用这些技术分析粒子个体和大数属性(例如大小、形状、表面积、粗度、密度、溶性、晶体形式、流流、粘和微结构)。For greater insight, drug substance-excipient physical (e.g., segregation and compaction) and chemical (e.g., compatibility) interactions are also discussed.

Read the article here

Article information: Parind M.德赛 赖华昌 保尔万夏兴Handbook of Pharmaceutical Granulation Technology, 2021.

Der Beitrag Drug Substance and Excipient Characterization erschien zuerst auf Pharma Excipients.

Granules和Papt使用生态友好粒子法绿色流化Bed粒子比直接压缩//www.novoestroim.com/granulation/green-fluidized-bed-granulation/ Philippe语言 2021年5月5日wed 2.30:34+00 巴斯夫 宾德 克罗波维多 杜邦Pharma Evonik 缩放式 晶体 磁子Stearate 微晶体细胞 波维多斯 启动程序 配方 //www.novoestroim.com/?p=219707
Green Fluidized Bed Granulation

This study aimed to compare the manufacturability and granule and tablet properties of green fluidized bed granulation (GFBG) and of direct compression (DC).Actaminophen使用低压性仿真药GFBG生产最终混合物的流程时间与DC相似,因此GFBG可被视为sss//ps/derBeitrag

Green Fluidized Bed Granulation

This study aimed to compare the manufacturability and granule and tablet properties of green fluidized bed granulation (GFBG) and of direct compression (DC).Actaminophen使用低压性仿真药GFBG生产最终混合物过程时间与DC相似,因此GFBG可被视为简单过程DC无法生产30%药荷片,原因是微粒流性差,而GFBG表列过程未发现问题达药载量的80%。

使用GFBG准备表比用DC准备表强可压缩性评价结果显示,用GFBG制片的粒子增压比DC低得多,表示用GFBG制片的粒子易塑变形此外,与GFBG制作平板显示快速分解比DC快We conclude that GFBG produces granules with higher drug content and desired physicochemical prop- erties at low cost.

Download the full article here: Manufacturability and Properties of Granules and Tablets Using the Eco-Friendly Granulation Method Green Fluidized Bed Granulation Compared to Direct Compression

or continue reading here: Agata Ishikawa, Hiroshi Takasaki, Atsushi Sakurai, Takuma Katayama, Koichi Wada, Takayuki Furuishi, Kaori Fukuzawa, Yasuko Obata, Etsuo Yonemochi, Manufacturability and Properties of Granules and Tablets Using the Eco-Friendly Granulation Method Green Fluidized Bed Granulation Compared to Direct Compression, Chemical and Pharmaceutical Bulletin, 2021, Volume 69, Issue 5, Pages 447-455, Released May 01, 2021, Online ISSN 1347-5223, Print ISSN 0009-2363, https://doi.org/10.1248/cpb.c20-00970, https://www.jstage.jst.go.jp/article/cpb/69/5/69_c20-00970/_article/-char/en

Materials
Lactose monohydrate and agglomerated lactose (Granulac 200 and Tablettose 80, respectively) from Meggle (Wasserburg, Germany), polyvidone (Povidone K12) and crospovidone (Kollidon CL) from BASF (Ludwigshafen, Germany), microcrystalline cellulose (Avicel PH102 SCG) from FMC (Philadelphia, PA, U.S.A.), colloidal silicon dioxide (Aerosil 200) from Degussa (Frankfurt, Germany), and magnesium stearate (magnesium stearate vegetable) from Faci (Carasco, Italy).

Der Beitrag Manufacturability and Properties of Granules and Tablets Using the Eco-Friendly Granulation Method Green Fluidized Bed Granulation Compared to Direct Compression erschien zuerst auf Pharma Excipients.

PAT和机械建模工具组合完全连续粉状粒线:快速深入过程理解//www.novoestroim.com/continuous-manufacturing/fully-continuous-granulation-line-pat/ Philippe语言 元2021年5月3日053452+00 Acrylic聚合器 巴斯夫 连续制造 缩放式 晶体 Megle游戏 新闻发布 Petro化工 波维多斯 罗奎特 星空 启动程序 配方 //www.novoestroim.com/?p=219306
Combination of PAT and mechanistic modeling tools in a fully continuous powder to granule line

Comprehensive understanding of an integrated continuous pharmaceutical technology was achieved in this study by a combining design of experiments and mechanistic modeling-based simulations.粉粒线由双螺旋湿粒化、振动液槽干燥和磨粉组成偏最小方块回归模型构建时使用近红外光谱监测 [.]

derBeitrag

Combination of PAT and mechanistic modeling tools in a fully continuous powder to granule line

Comprehensive understanding of an integrated continuous pharmaceutical technology was achieved in this study by a combining design of experiments and mechanistic modeling-based simulations.粉粒线由双螺旋湿粒化、振动液槽干燥和磨粉组成偏最小方块回归模型构建后使用近红外光谱实时监测产品湿度步数。

a拆分全因子实验设计建立并实现帮助理解水分内容和进程参数之间的关系此外,还搭建了机械模型,涉及干燥空气和固态材料之间的热传导未知运动模型参数使用实验研究结果估计,结果标定和验证性能良好The simulations not only reinforced the experimental observations but also paves the way for model-based process monitoring and optimal control.

Download the full article here: Combination of PAT and mechanistic modeling tools in a fully continuouspowder to granule line

or continue reading here: András Domokos, Éva Pusztai, Lajos Madarász, Brigitta Nagy, Martin Gyürkés, Attila Farkas, Gergő Fülöp, Tibor Casian, Botond Szilágyi, Zsombor Kristóf Nagy, Combination of PAT and mechanistic modeling tools in a fully continuous powder to granule line: Rapid and deep process understanding, Powder Technology, Volume 388,
2021, Pages 70-81, ISSN 0032-5910, https://doi.org/10.1016/j.powtec.2021.04.059 (https://www.sciencedirect.com/science/article/pii/S0032591021003466)

Materials
For the granulation experiments, α-lactose monohydrate (Granu-Lac® 70) and corn starch were applied in the starting powder blend.a hrefss/www.pharmaexsubjects.com/?filter_manfacturer=roquete净化水用 连续双螺旋粒子:微晶素批量变异在颗粒和干燥期间-QbD方法//www.novoestroim.com/news/twin-screw-granulation-mcc-qbd/ 汤姆 2021年4月01日0:30:31+00 杜邦Pharma 配方 缩放式 微晶体细胞 新闻发布 启动程序 //www.novoestroim.com/?p=212248

graphical abstract of Continuous twin screw granulation Impact of microcrystalline cellulose batch-to-batch variability during granulation and drying – A QbD approach

Despite significant advances in the research domain of continuous twin screw granulation, limited information is currently available on the impact of raw material properties, especially considering batch-to-batch variability.原始材料易变性及随后减轻这种易变性对制造过程和药产品影响的重要性最近通过ss/www.pharmaexsubjects.com/news/twin-scrue-granulation-mcc-qbd/

graphical abstract of Continuous twin screw granulation Impact of microcrystalline cellulose batch-to-batch variability during granulation and drying – A QbD approach

Despite significant advances in the research domain of continuous twin screw granulation, limited information is currently available on the impact of raw material properties, especially considering batch-to-batch variability.原材料可变性的重要性并随后减轻这种可变性对制造过程和药产品的影响最近在美国连续制造质量考量行业指南草稿中得到了强调食品药管局(FDA)

因此,本研究评估微晶素纤维素分批变异和流程设置在连续双螺旋湿和半连续干线中的影响素材特征分析后主组件分析基础,素材变异性量化地引入T+++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++L/S比对临界粒子属性和可处理性比螺丝速度和干燥时间产生更大效果t1和t2评分大效果显示原材料属性的重要性。

并提议用创新量化方法来减少批量对批量变异性--批量-批量-批量-批量-批量-批量-驱动----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------国际药理学杂志X卷32021https://doi.org/10.1016/j.ijpx.2021.100077.

Materials: Microcrystalline Cellulose (Avicel PH-101), lactose

Der Beitrag Continuous twin screw granulation: Impact of microcrystalline cellulose batch-to-batch variability during granulation and drying – A QbD approach erschien zuerst auf Pharma Excipients.

临界物属性粒子形状对微量药厂操作//www.novoestroim.com/binder/impact-of-particle-shape/ Philippe语言 2021年3月17日10:30:22+00 宾德 Cabot公司 协同处理前接收器 分解/超分解 填充器 滑动图 缩放式 JRS药厂 润滑油 磁子Stearate 马尔林克罗德 微晶体细胞 新闻发布 西里卡 水星Glyolate 声波丰田 启动程序 配方 //www.novoestroim.com/?p=208793
Impact of Critical Material Attributes (CMAs)-Particle Shape on Miniature Pharmaceutical Unit Operations

The U.S.食品药管局强调按质量设计开发药产品临界物属性(CMAs)为QbD元素,对药厂和产品质量有影响药用药常像针形粒子晶化作用并影响过程,原因包括流性差、散度密度低和 [.]

Beitrag 关键物属性作用-粒子形状微集运算 erschienzusta

Impact of Critical Material Attributes (CMAs)-Particle Shape on Miniature Pharmaceutical Unit Operations

The U.S.食品药管局强调按质量设计开发药产品临界物属性(CMAs)为QbD元素,对药厂和产品质量有影响药用药常结晶成针形粒子并因易流性、低散密度和高压缩性能而影响过程。

挖掘小量材料并破针,多可用设备(摩塔-spetle、Krups研磨机)和定制研磨机在配制前经过评估处理后CIPRO粉末后用于制作MIT团队开发的微型片片制造单元片片由美国药店设置的药片关键质量属性后评估每种设备处理的药粉。

药粉属性与商业CIPRO相似针形晶体如何对药用操作产生作用,即使它规模微小,通过MIT团队设计研磨机处理粒子可获取适当的形状和后续流性.

et al.springer.com/article/10.1208/s12249-020915-6AAPS药理技术22,98(2021年)。https://doi.org/1280/s12249020901915-6 matiles coproxacin盐酸单水合物(CIPRO,99.8%纯度)从Jai Radhe销售公司(印度Gujrat)购买并使用为示范药批量密度、压缩性能、稳定性/目标架存存寿命等决定了选择药产品设计前接受者稳定改善前接受者不被视为按需制造设计开发简化法通过减少按表所需前接收者数目来讨论。因此,只选择一个填充者/二流者/滑动帮助/滑动和润滑smcc-hd-90/sprosolv-smcc-hd-90/KG (德国Rosenberg)并被视为填/二二二二二二二二二.png'alt=TM类最大高度为1em;'/>,由Mallinckrodt药厂(MO,USA)提供,被视为润滑剂Sordium starkglycolate (sss-sectionjs-sectionjs-c-read-complication-section-药厂操作对粒子形状敏感,特别是显示高方位比的系统磨坊药厂中人所共知处理小量粉末时,商业上没有微量设备可用麻省理工学院设计了一个研磨机集成滤波干粉平板属性满足USP标准,拆分剖面像商业CIPRO平板总体结果比较系统常用替代物显示针形对制药过程有影响,甚至在微量规模上也是如此。麻省理工学院设计研磨机克服了这些挑战.

Der Beitrag 使用新颖重力高速压缩法评价药粉的机械性能和可平面性//www.novoestroim.com/news/novel-gravitation-based-high-velocity-compaction-method/ Philippe语言 元2021年3月15日13:30:18+00 宾德 布顿海姆 钙磷酸盐 DFE药店 分解/超分解 杜邦Pharma 缩放式 JRS药厂 晶体 磁子Stearate 微晶体细胞 新闻发布 星空 启动程序 配方 //www.novoestroim.com/?p=208294

Schematic representation of the gravitation-based high-speed compaction device

Developing new pharmaceuticals is costly and time-consuming.各种产品开发阶段总需要新方法。早期开发投资从长远看可省下大量资源。平板仍然是最常用药用量表平板常通过粉末压缩生成Powder [.]

DerBeitrag

Schematic representation of the gravitation-based high-speed compaction device

Developing new pharmaceuticals is costly and time-consuming.各种产品开发阶段总需要新方法。早期开发投资从长远看可省下大量资源 。
表仍然是最常用药用量表平板常通过粉末压缩生成粉状粒子碎片变形压强 允许新联结形成现代机器每小时可产生100万片片以上。
举例说,过强弹性混合粉末可产生弱或偏差片片因此,机械特性需要研究设备平板模拟器设计帮助开发适当的平板配方机器实用性强 但仍可相当贵大由这些机器获取的结果并非总是普遍适用,往往需要进一步解释 。
本论文开发出新颖的重力高速压缩法,以成本高效直截面研究粉末压缩和可平面性方法基础为自由下降钢棒,它压缩火药样本嵌入自定义死法条形变换波由高精度移位传感器监控移位图再推导方法获取的所有数据归根结底都只基于置换数据。MCC显示比 stark系统更压缩和弹性小可见相对量下降和压缩行为方面的表面差异。
下一步,对各种材料进行更全面的研究使用两种压力不等的不同搭建甘蓝等级和甘蓝显示有效分片并同时搭建达到真密度MCC等级明显依赖压力并显示慢度渐变形,表示塑料行为压缩压力不够高,无法有效分解磷酸Stark显示所有样本最弹性概括地说,所有受审查材料都可按机械特性成功分类 。
最后,通过创建模型显示方法的实际相关性,模型通过G-HVC方法确定的紧凑能值与平板机生成片容强度三种不同的配方由MCC、磷酸钙、Tephylline和HPPC组成,使用流水床系统粒化压缩能和抗拉强度有良好的关联性.
总之,G-HVC法证明是检验粉末机械性能的可靠成本效益工具方法还能够产生实际相关结果。The method fits well in modern pharmaceutical research where material-sparing, straightforward and reliable methods are in demand.

Download the full Disseration here: Evaluating mechanical properties and tabletability of pharmaceutical powders with a novel gravitation-based high-velocity compaction method

by Timo Tanner – Division of Pharmaceutical Chemistry and Technology Faculty of Pharmacy, University of Helsinki, Finland

Materials
A total of 12 different materials was studied, including Amioca powder TF (National Starch), anhydrous calcium hydrogen phosphate (Merck), anhydrous glucose Ph.欧尔a href=s/www.pharmaexsubjects.com/exime-suppliers/budenhi磁铁Ph欧尔Yliopiston Apteekki曾用于某些配方润滑剂,还混合技术级acetone产生5 w/w(%)混合来润滑设备Avisel和Vivapur分级CCC、HPMC选择材料展示机械性能的广度.

derBeitrag
小型ODTs和硬币形状ODTs应用高性能前接收器编程//www.novoestroim.com/news/mini-coin-shaped-odts-pediatric/ 汤姆 Thu,2021年2月18日10:30:28+00 克罗波维多 戴赛尔 DC前接收器 缩放式 微晶体细胞 新闻发布 启动程序 配方 //www.novoestroim.com/?p=203260
Application of mini ODTs and coin shaped ODTs with high performance excipients for pediatric preparation

Pediatric formulations are strongly demanded from healthcare professionals and caregivers.固态用量表目前作为儿科准备研究文章中,我们报告口服分解片片开发情况,这些片段适合小数配方,内含高性能前接受者GRANSILER-DTM和HISORDTM微型平面板从s/s/a/schienzuerst aufss/noforcems.com/news/mini-coin-ods-pedicries/

Application of mini ODTs and coin shaped ODTs with high performance excipients for pediatric preparation

Pediatric formulations are strongly demanded from healthcare professionals and caregivers.固态分解平方块开发dgrefs/s/granfss/sss/sssssss/sorad-hsr-d03/微型ODTs使用GRANSLER-DsupTM/sup平板两片分解时间小3秒,对任何微型平板测量设备都显示足够硬易碎性。

Coin形状ODTs直径大,约14毫米薄薄薄,厚度1毫米期望它们快速分解,因为其大面积面积安慰板分解时间 < 5秒并展示实用易碎值 < 0.5%,并下降测试50平板电脑dssup TM/sup_/a/a/ahref=s//ss/servad-exips/hisord-servict-od-od-od-od-od-od-od-od-ods/a hrefss/www.pharmaexbidents.com/?ss=daicels&post_sssss= true&id=1&filter=1Furthermore, the distinctive properties also allow tablets to be miniaturized and made thinner.

MORE ON DAICEL

Application of mini ODTs and coin shaped ODTs with high performance excipients for pediatric preparationDownload the full article as a PDF here


Sample Request for DAICEL excipients:

Der Beitrag Application of mini ODTs and coin shaped ODTs with high performance excipients for pediatric preparation erschien zuerst auf Pharma Excipients.